# Vitalant – FDA Inspection, Aug 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/3a9b71cb-e049-49a7-b46e-ccb93a0ceabe
Source feed: FDA_Inspections

> FDA inspection 1106251 of Vitalant, August 19, 2019. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106251
- Company Name: Vitalant
- Inspection Date: 2019-08-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1233322 - 2024-03-13
- FDA Inspection 945649 - 2015-10-19
- FDA Inspection 852226 - 2013-10-22
- FDA Inspection 756175 - 2011-12-06
- [FDA Inspection 628530 - 2009-11-10](https://www.keypedia.com/records/fda_inspections/vitalant/a05b6dde-0b5c-4ead-96bd-7118dc5b6451)

## Related Officers

- [Investigator](https://www.keypedia.com/people/carl-e-lovrich/28ad3898-eaac-4f07-8dc5-09bda890c63a)
- [Company Rep](https://www.keypedia.com/people/erika-m-wilkerson/cd1c299d-c827-4d52-8e2b-719989da9991)

Company: https://www.keypedia.com/companies/vitalant/3b4bcbc3-8581-4717-a386-60e17d1639bc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d